International Multisite Transcatheter Tricuspid Valve Therapies Registry Read more about International Multisite Transcatheter Tricuspid Valve Therapies Registry
A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma Read more about A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure Read more about Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Pomalidomide Treatment in Patients With Kaposi Sarcoma Read more about Pomalidomide Treatment in Patients With Kaposi Sarcoma
A Peer-Led Intervention to Improve Postpartum Retention in HIV Care Read more about A Peer-Led Intervention to Improve Postpartum Retention in HIV Care
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia Read more about An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia
Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma Read more about Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008, KEYVIBE-008) Read more about Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008, KEYVIBE-008)
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer Read more about Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer Read more about Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer